A detailed history of Bradley & Co. Private Wealth Management, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bradley & Co. Private Wealth Management, LLC holds 304 shares of TXG stock, worth $4,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
304
Previous 304 -0.0%
Holding current value
$4,809
Previous $11,000 54.55%
% of portfolio
0.0%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 21, 2022

BUY
$28.48 - $52.59 $8,657 - $15,987
304 New
304 $9,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Bradley & Co. Private Wealth Management, LLC Portfolio

Follow Bradley & Co. Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley & Co. Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bradley & Co. Private Wealth Management, LLC with notifications on news.